Search Results - Philip S. Watson

Refine Results
  1. 1
    Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer

    Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer by Philip A. Watson, Vivek Arora, Charles L. Sawyers

    Published 2015
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Androgen Receptor Signaling in Salivary Gland Cancer

    Androgen Receptor Signaling in Salivary Gland Cancer by Martin G. Dalin, Philip A. Watson, Alan L. Ho, Luc G.T. Morris

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Mutations of the<i>PDS</i>Gene, Encoding Pendrin, Are Associated with Protein Mislocalization and Loss of Iodide Efflux: Implications for Thyroid Dysfunction in Pendred Syndrome

    Mutations of the<i>PDS</i>Gene, Encoding Pendrin, Are Associated with Protein Mislocalization and Loss of Iodide Efflux: Implications for Thyroid Dysfunction in Pendred Syndrome by Julie P. Taylor, Russell Metcalfe, Philip F. Watson, Anthony P. Weetman, Richard C. Trembath

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    The Calcium-Sensing Receptor Is a Target of Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1

    The Calcium-Sensing Receptor Is a Target of Autoantibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1 by Nikos Gavalas, E. Helen Kemp, Kai Krohn, Edward M. Brown, Philip F. Watson, Anthony P. Weetman

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Activating Autoantibodies against the Calcium-Sensing Receptor Detected in Two Patients with Autoimmune Polyendocrine Syndrome Type 1

    Activating Autoantibodies against the Calcium-Sensing Receptor Detected in Two Patients with Autoimmune Polyendocrine Syndrome Type 1 by E. Helen Kemp, Nikos Gavalas, Kai Krohn, Edward M. Brown, Philip F. Watson, Anthony P. Weetman

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Murine Cell Lines Derived from <i>Pten</i> Null Prostate Cancer Show the Critical Role of PTEN in Hormone Refractory Prostate Cancer Development

    Murine Cell Lines Derived from <i>Pten</i> Null Prostate Cancer Show the Critical Role of PTEN in Hormone Refractory Prostate Cancer Development by Jing Jiao, Shunyou Wang, Rong Qiao, Igor Vivanco, Philip A. Watson, Charles L. Sawyers, Hong Wu

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    A shift in the Bax/Bcl-2 balance may activate caspase-3 and modulate apoptosis in experimental glomerulonephritis

    A shift in the Bax/Bcl-2 balance may activate caspase-3 and modulate apoptosis in experimental glomerulonephritis by Bin Yang, Timothy S. Johnson, Graham L. Thomas, Philip F. Watson, Bart Wagner, Peter Furness, A. Meguid El Nahas

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor

    Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor by Philip A. Watson, Yinan F. Chen, Minna Balbas, John Wongvipat, Nicholas D. Socci, Agnès Viale, Kwanghee Kim, Charles L. Sawyers

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Overcoming mutation-based resistance to antiandrogens with rational drug design

    Overcoming mutation-based resistance to antiandrogens with rational drug design by Minna Balbas, Michael J. Evans, David J. Hosfield, John Wongvipat, Vivek Arora, Philip A. Watson, Yu Chen, Geoffrey L. Greene, Yang Shen, Charles L. Sawyers

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo

    The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo by E. Helen Kemp, Elizabeth A. Waterman, Brian E. Hawes, Kim O’Neill, Raju V.S.R.K. Gottumukkala, David J. Gawkrodger, Anthony P. Weetman, Philip F. Watson

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo

    The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo by E. Helen Kemp, Elizabeth A. Waterman, Brian E. Hawes, Kim O’Neill, Raju V.S.R.K. Gottumukkala, David J. Gawkrodger, Anthony P. Weetman, Philip F. Watson

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes

    FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes by Elizabeth Adams, Wouter R. Karthaus, Elizabeth Hoover, Deli Liu, Antoine Gruet, Zeda Zhang, Hyunwoo Cho, Rose DiLoreto, Sagar Chhangawala, Yang Liu, Philip A. Watson, Elai Davicioni, Andrea Sboner, Christopher E. Barbieri, Rohit Bose, Christina Leslie, Charles L. Sawyers

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer

    Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer by Chris Tran, Samedy Ouk, Nicola J. Clegg, Yu Chen, Philip A. Watson, Vivek Arora, John Wongvipat, Peter Smith‐Jones, Dongwon Yoo, Andrew Kwon, Teresa Wasielewska, Derek S. Welsbie, Charlie Degui Chen, Celestia S. Higano, Tomasz M. Beer, David T. Hung, Howard I. Scher, Michael E. Jung, Charles L. Sawyers

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer

    Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer by Michael R. McDevitt, Daniel L.J. Thorek, Takeshi Hashimoto, Tatsuo Gondo, Darren R. Veach, Sai Kiran Sharma, Teja Kalidindi, Diane S. Abou, Philip A. Watson, Bradley J. Beattie, Oskar Vilhemsson Timmermand, Sven‐Erik Strand, Jason S. Lewis, Peter T. Scardino, Howard I. Scher, Hans Lilja, Steven M. Larson, David Ulmert

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Allosteric interactions prime androgen receptor dimerization and activation

    Allosteric interactions prime androgen receptor dimerization and activation by Elizabeth V. Wasmuth, Arnaud Vanden Broeck, Justin LaClair, Elizabeth A. Hoover, Kayla E. Lawrence, Navid Paknejad, Kyrie Pappas, Doreen Matthies, Biran Wang, Weiran Feng, Philip A. Watson, John C. Zinder, Wouter R. Karthaus, M. Jason de la Cruz, Richard K. Hite, Katia Manova‐Todorova, Zhiheng Yu, Susan T. Weintraub, Sebastian Klinge, Charles L. Sawyers

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    <i>SOX2</i> promotes lineage plasticity and antiandrogen resistance in <i>TP53</i> - and <i>RB1</i> -deficient prostate cancer

    <i>SOX2</i> promotes lineage plasticity and antiandrogen resistance in <i>TP53</i> - and <i>RB1</i> -deficient prostate cancer by Ping Mu, Zeda Zhang, Matteo Benelli, Wouter R. Karthaus, Elizabeth Hoover, Chi-Chao Chen, John Wongvipat, Sheng‐Yu Ku, Dong Gao, Zhen Cao, Neel Shah, Elizabeth Adams, Wassim Abida, Philip A. Watson, Davide Prandi, Chun‐Hao Huang, Elisa de Stanchina, Scott W. Lowe, Leigh Ellis, Himisha Beltran, Mark A. Rubin, David W. Goodrich, Francesca Demichelis, Charles L. Sawyers

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Androgen Receptor Signaling Regulates DNA Repair in Prostate Cancers

    Androgen Receptor Signaling Regulates DNA Repair in Prostate Cancers by William R. Polkinghorn, Joel S. Parker, Man X. Lee, Elizabeth M. Kass, Daniel E. Spratt, Phillip J. Iaquinta, Vivek Arora, Wei-Feng Yen, Ling Cai, Deyou Zheng, Brett S. Carver, Yu Chen, Philip A. Watson, Neel Shah, Sho Fujisawa, Alexander G. Goglia, Anuradha Gopalan, Haley Hieronymus, John Wongvipat, Peter T. Scardino, Michael J. Zeléfsky, Maria Jasin, Jayanta Chaudhuri, Simon N. Powell, Charles L. Sawyers

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Somatic Tissue Engineering in Mouse Models Reveals an Actionable Role for WNT Pathway Alterations in Prostate Cancer Metastasis

    Somatic Tissue Engineering in Mouse Models Reveals an Actionable Role for WNT Pathway Alterations in Prostate Cancer Metastasis by Josef Leibold, Marcus Ruscetti, Zhen Cao, Yu-Jui Ho, Timour Baslan, Min Zou, Wassim Abida, Judith Feucht, Teng Han, Francisco M. Barriga, Kaloyan M. Tsanov, Leah Zamechek, Amanda Kulick, Corina Amor, Sha Tian, Katarzyna Rybczyk, Nelson R. Salgado, Francisco J. Sánchez‐Rivera, Philip A. Watson, Elisa de Stanchina, John E. Wilkinson, Lukas E. Dow, Cory Abate‐Shen, Charles L. Sawyers, Scott W. Lowe

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwide

    Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwide by Alessandro Muzzi, Alessandro Brozzi, Laura Serino, Margherita Bodini, Raquel Abad, Dominique A. Caugant, Maurizio Comanducci, Ana Paula Silva de Lemos, Maria Cecília Gorla, Pavla Křížová, Claudia Mikula, Robert Mulhall, Michael D. Nissen, Hanna Nohynek, Maria João Simões, Anna Skoczyńska, Paola Stefanelli, Muhamed‐Kheir Taha, Maija Toropainen, Georgina Tzanakaki, Kumaran Vadivelu-Pechai, Philip S. Watson, Julio A. Vázquez, Gowrisankar Rajam, Rino Rappuoli, Ray Borrow, Duccio Medini

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Targeting prostate tumor low–molecular weight tyrosine phosphatase for oxidation-sensitizing therapy

    Targeting prostate tumor low–molecular weight tyrosine phosphatase for oxidation-sensitizing therapy by Stephanie M. Stanford, Tiffany P. Nguyen, Joseph T. Chang, Zixuan Zhao, G. Lavender Hackman, Eugenio Santelli, Colton M. Sanders, Madhusudhanarao Katiki, Eleonora Dondossola, Brooke L. Brauer, Michael A. Diaz, Yuan Zhan, Sterling H. Ramsey, Philip A. Watson, Banumathi Sankaran, Claudia Paindelli, Vanessa Parietti, Antonios G. Mikos, Alessia Lodi, Aditya Bagrodia, Andrew Elliott, Rana R. McKay, Ramachandran Murali, Stefano Tiziani, Arminja N. Kettenbach, Nunzio Bottini

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: